Proposed Diagnostic Criteria for Chronic Antibody-Mediated Rejection in Liver Allografts

Jacqueline G. O'Leary, J. Cai, R. Freeman, N. Banuelos, B. Hart, M. Johnson, L. W. Jennings, H. Kaneku, P. I. Terasaki, G. B. Klintmalm, A. J. Demetris

Research output: Contribution to journalArticle

47 Scopus citations

Abstract

Donor-specific alloantibodies (DSA) can cause acute antibody-mediated rejection (AMR) in all solid organ allografts. However, long-term outcome in patients with posttransplant DSA needs further study. We retrospectively evaluated prospectively collected paired serum, tissue, and data on 45 matched DSA- positive [DSA+; mean florescence intensity (MFI) ≥10 000] and -negative (DSA-) recipients of a primary liver-only allograft from January 2000 to April 2009. Blinded histopathologic evaluation demonstrated that DSA+ versus DSA- patients were more likely to have subtle inflammation and unique patterns of fibrosis, despite normal or near-normal liver function tests. Stepwise multivariable modeling developed a score (putatively named the chronic AMR [cAMR] score) that included interface activity, lobular inflammation, portal tract collagenization, portal venopathy, sinusoidal fibrosis, and hepatitis C virus status. The score was developed (c = 0.811) and cross-validated (c = 0.704) to predict allograft failure. Two cutoffs were employed to optimize sensitivity and specificity (80% each); a value >27.5 predicted 50% 10-year allograft failure. We propose chronic AMR as a potential new entity defined by (1) a high cAMR score, (2) DSA, and (3) elimination of other potential causes of a similar injury pattern. In conclusion, cAMR score calculation identified liver allograft recipients with DSA at highest risk for allograft loss, although independent validation is needed.

Original languageEnglish (US)
Pages (from-to)603-614
Number of pages12
JournalAmerican Journal of Transplantation
Volume16
Issue number2
DOIs
StatePublished - Feb 1 2016

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Proposed Diagnostic Criteria for Chronic Antibody-Mediated Rejection in Liver Allografts'. Together they form a unique fingerprint.

  • Cite this

    O'Leary, J. G., Cai, J., Freeman, R., Banuelos, N., Hart, B., Johnson, M., Jennings, L. W., Kaneku, H., Terasaki, P. I., Klintmalm, G. B., & Demetris, A. J. (2016). Proposed Diagnostic Criteria for Chronic Antibody-Mediated Rejection in Liver Allografts. American Journal of Transplantation, 16(2), 603-614. https://doi.org/10.1111/ajt.13476